Currently there is very little to offer the chronic headache patient. Nearly two thirds of patients discontinue prescription medications due to inadequate relief and side-effects.
SPG blocks achieve neuromodulation of the sphenopalatine ganglion complex. This means that the time-tested efficacy of the procedure has been shown to have both immediate and sustained results. These effects are typically sustained by interrupting the chaotic signaling associated with migraine.
Although proven effective, few physicians offer the SPG block to patients because the traditional procedures are uncomfortable for the patient and demanding for the care giver. Traditionally, the block is attempted by navigating a cotton tip applicator through the nasal passages or with a long needle through the side of the head. These approaches carry risks and sometimes require sedation.
Today, establishing an SPG block has never been easier. The patented SphenoCath® offers the practitioner the ability to offer a first-line treatment to the chronic headache patient. The SphenoCath® delivers medication that can sustain pain relief in a 15 minute procedure that is comfortable and quick. With the SphenoCath® an SPG block may be achieved without needles, cotton swabs, atomizer sprays, or systemic narcotics.